Biotech · Private company
DynPort Vaccine Company LLC, A GDIT Company
Track this companyFree. Adds DynPort Vaccine Company LLC, A GDIT Company to your Dealase workspace and tells you when its record changes.
Clinical trials30 recruiting or active
Pipeline programs2From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline2
- rF1V vaccine (with Adjuvant)Phase 2 · Plague VaccineClinicalTrials.gov · fetched Nov 12, 2026
- rF1V vaccine (without Adjuvant)Phase 2 · Plague VaccineClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials3
- Randomized Single-Blinded Study to Evaluate Safety and Immunogenicity of Recombinant Plague Vaccine With and Without AdjuvantPHASE2 · COMPLETED · started Jul 1, 2010ClinicalTrials.gov NCT01122784 · fetched Nov 12, 2026
- A Study of Plasma-Derived Human Butyrylcholinesterase Administered IntramuscularlyPHASE1 · COMPLETED · started Dec 1, 2007ClinicalTrials.gov NCT00333528 · fetched Nov 12, 2026
- Pharmacokinetic (PK) and Safety Study of Plasma-derived Human Butyrylcholinesterase Administered IntravenouslyPHASE1 · COMPLETED · started Jan 1, 2007ClinicalTrials.gov NCT00333515 · fetched Nov 12, 2026